Document Detail

A disease-relevant high-content screening assay to identify anti-inflammatory compounds for use in cystic fibrosis.
MedLine Citation:
PMID:  20944057     Owner:  NLM     Status:  In-Data-Review    
Chronic lung inflammation caused by bacterial pathogenesis through activation of nuclear factor kappa B (NFκB)-responsive proinflammatory genes is a major hurdle in the management of lung disease in cystic fibrosis (CF) patients. The authors generated a disease-relevant cell-based high-content screen to identify novel anti-inflammatory compounds for treating lung inflammation in CF. The human bronchial epithelial cell line KKLEB, harboring the most common form of mutation that causes CF, was modified to express an NFκB-responsive green fluorescent protein (GFP) reporter. After creation, the cell line was tested for its ability to respond to disease-relevant inflammatory stimuli elicited by treatment of cells with filtrates of Pseudomonas aeruginosa isolated from the airways of a CF patient. P. aeruginosa filtrates potently activated NFκB-responsive GFP reporter expression in cells. Subsequently, the assay was optimized for high-throughput screening (HTS) through generation of a Z factor (~0.5) and by testing its tolerance to the commonly used solvents ethanol and DMSO. A pilot library of clinically approved compounds was screened for assay validation. Several compounds with known NFκB inhibitory activity were identified, including several steroidal compounds that have been clinically tested in CF. Thus, the assay can be used in a broader HTS campaign to find anti-inflammatory agents for use in CF.
Angela M Giddings; Rangan Maitra
Related Documents :
10986637 - Infection, neutrophils, and hematopoietic growth factors in the pathogenesis of neonata...
10445407 - Expression of xenobiotic-metabolizing cyps in human pulmonary tissue.
20944057 - A disease-relevant high-content screening assay to identify anti-inflammatory compounds...
20105457 - Cadmium-induced inflammatory responses in cells relevant for lung toxicity: expression ...
15957187 - Immortalized human microglial cell line: phenotypic expression.
22581907 - Novel immunomodulatory function of 1,3,4-thiadiazole derivatives with leishmanicidal ac...
Publication Detail:
Type:  Journal Article     Date:  2010-10-13
Journal Detail:
Title:  Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening     Volume:  15     ISSN:  1552-454X     ISO Abbreviation:  J Biomol Screen     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9612112     Medline TA:  J Biomol Screen     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1204-10     Citation Subset:  IM    
Department of Pharmacology and Toxicology, Discovery Sciences, RTI International, Research Triangle Park, NC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Translating the diabetes prevention program for Northern Plains Indian youth through community-based...
Next Document:  Ethical practice in sex offender assessment: consideration of actuarial and polygraph methods.